These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 3007163)

  • 1. Effect of metoprolol and propranolol on platelet aggregation and cAMP level in hypertensive patients.
    Winther K; Knudsen JB; Gormsen J; Jensen J
    Eur J Clin Pharmacol; 1986; 29(5):561-4. PubMed ID: 3007163
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of three beta-blockers with different pharmacodynamic properties on platelet aggregation and platelet and plasma cyclic AMP.
    Winther K; Trap-Jensen J
    Eur J Clin Pharmacol; 1988; 35(1):17-20. PubMed ID: 2905989
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The difference between non-selective and beta 1-selective beta-blockers in their effect on platelet function in migraine patients.
    Hedman C; Winther K; Knudsen JB
    Acta Neurol Scand; 1986 Dec; 74(6):475-8. PubMed ID: 3030039
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of chronic treatment with adrenaline or propranolol on platelet function and c-AMP levels in the rat.
    Terres W; Becker BF; Schrödl W; Gerlach E
    Cardiovasc Res; 1989 Feb; 23(2):112-6. PubMed ID: 2550130
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The peripheral platelet count and ADP-induced platelet aggregation in response to metoprolol and propranolol as studied in young healthy male volunteers.
    Vilén L; Kutti J; Fredén K; Lundborg P; Cronberg S
    Scand J Haematol; 1983 Nov; 31(5):440-6. PubMed ID: 6648357
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of bupranolol, a new beta-blocker, on platelet functions of rabbit and human in vitro.
    Umetsu T; Sanai K; Kato T
    Thromb Haemost; 1976 Nov; 36(2):376-87. PubMed ID: 12593
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the effects of carvedilol, propranolol, and verapamil on in vitro platelet function in healthy volunteers.
    Gasser JA; Betterridge DJ
    J Cardiovasc Pharmacol; 1991; 18 Suppl 4():S29-34. PubMed ID: 1721976
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of beta-blockade on platelet function and fibrinolytic activity.
    Winther K
    J Cardiovasc Pharmacol; 1987; 10 Suppl 2():S94-8; discussion S99. PubMed ID: 2481178
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Platelet activity and selective beta-blockade in migraine prophylaxis.
    Joseph R; Steiner TJ; Schultz LU; Clifford Rose F
    Stroke; 1988 Jun; 19(6):704-8. PubMed ID: 2897733
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of beta-adrenoceptor blockade by metoprolol and propranolol on plasma concentrations and effects of noradrenaline and adrenaline during i.v. infusion.
    Hjemdahl P; Akerstedt T; Pollare T; Gillberg M
    Acta Physiol Scand Suppl; 1983; 515():45-53. PubMed ID: 6312744
    [No Abstract]   [Full Text] [Related]  

  • 11. Exercise-induced platelet aggregation in angina and its possible prevention by beta 1-selective blockade.
    Winther K; Rein E
    Eur Heart J; 1990 Sep; 11(9):819-23. PubMed ID: 1977586
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of some beta blockers (pindolol, atenolol, timolol and metoprolol) on aggregation and arachidonic acid metabolism in human platelets.
    Srivastava KC
    Prostaglandins Leukot Med; 1987 Sep; 29(1):79-84. PubMed ID: 2890173
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of Carvedilol Versus Metoprolol on Platelet Aggregation in Patients With Acute Coronary Syndrome: The PLATE-BLOCK Study.
    Ilardi F; Gargiulo G; Schiattarella GG; Giugliano G; Paolillo R; Menafra G; De Angelis E; Scudiero L; Franzone A; Stabile E; Perrino C; Cirillo P; Morisco C; Izzo R; Trimarco V; Esposito G
    Am J Cardiol; 2018 Jul; 122(1):6-11. PubMed ID: 29747861
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of propranolol and metoprolol on glucose, cyclic AMP and insulin responses during pharmacologic hyperglucagonemia in hemodialysis patients.
    Pun KK; Yeung CK; Yeung RT
    Nephron; 1985; 39(3):175-8. PubMed ID: 2983250
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beta-adrenoceptor antagonists and human platelets: relationship of effects to lipid solubility.
    Kerry R; Scrutton MC; Wallis RB
    Biochem Pharmacol; 1984 Aug; 33(16):2615-22. PubMed ID: 6147145
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ADP-induced platelet aggregation and metoprolol treatment of myocardial infarction patients. A controlled study.
    Vilén L; Kutti J; Swedberg K; Vedin A
    Acta Med Scand; 1985; 217(1):15-20. PubMed ID: 3883701
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of platelet aggregation following chronic in vivo treatment of rats with nicotine: prevention by simultaneous application of propranolol.
    Terres W; Becker BF; Schrödl W; Gerlach E
    J Cardiovasc Pharmacol; 1989 Feb; 13(2):233-7. PubMed ID: 2468951
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of heparin and dihydroergotamine on platelet adenosine-3',5'-cyclic monophosphate.
    Zahavi M; Welzel D; Wolf H; Honey A; Kakkar VV
    Arzneimittelforschung; 1987 Jun; 37(6):669-74. PubMed ID: 2822055
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of long-acting propranolol and verapamil on blood pressure, platelet function, metabolic and rheological properties in hypertension.
    Ding YA; Chou TC; Lin KC
    J Hum Hypertens; 1994 Apr; 8(4):273-8. PubMed ID: 8021907
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of human platelet beta-adrenoceptors.
    Winther K; Klysner R; Geisler A; Andersen PH
    Thromb Res; 1985 Dec; 40(6):757-67. PubMed ID: 3003961
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.